CMS recently released their 2021 Medicare Advantage Readiness Checklist. GHG’s Jennifer Rogalla highlights key focus areas that may be new or expanded upon in 2021.
Strategy
Strategies to Support Value-Based Reimbursement During Uncertain Times
Amidst uncertainty, risk-bearing providers and ACOs must be nimble and adaptable to mitigate losses. What strategies can be deployed to support value-based financial and clinical goals?
MA Plans Should Pivot Due to COVID, Election Impact This Fall
In the fall, plans will be challenged by the double whammy of a presidential election and a predicted second outbreak of COVID-19. This AIS Health article in Health Plan Weekly shares some insights from a recent GHG/Deft Research webinar and the product strategy implications of a changed selling environment.
CMS Releases Interim Final Rule for COVID-19 Regulatory Changes
On March 30, 2020, CMS released the interim final rule with comment period (IFC) to address a variety of payment and provider practice needs in response to the COVID-19 pandemic. Read the key takeaways for Star Ratings, Provider Flexibilities, and Telehealth.
What’s New in the 2021 Final Rate Announcement for Medicare Advantage and Part D Plans?
The 2021 Medicare Advantage and Part D Rate Announcement finalizes the payment methodology and policies previously proposed by the Advance Notice. What’s been confirmed? Read this article for details.
Dramatic Changes to the Telehealth Benefit Due to COVID-19
CMS recently broadened access and greatly relaxed regulations around telehealth services for Medicare beneficiaries. What does this mean for Medicare Advantage plans and providers?
Remote Work in Challenging Times—Steps to Survive and Thrive
The reality of social distancing and “shelter in place” orders has forced many to find a new way of working outside of a physical office. Since GHG’s team is fully remote, we wanted to share some advice for those new to working from home.
Proposed MA Rule Floats Many Star Ratings Changes — Can Plans Keep Up?
GHG’s Senior Vice President of Stars & Strategy, Melissa Smith, talks crucial Star Ratings implications from the CMS 2021 and 2022 MA and Part D Proposed Rule in a recent AIS Health article in RADAR on Medicare Advantage.
5 Key Takeaways for Product Leaders from the Advance Notice
With bid submissions on the horizon, CMS’ recently announced Advance Notice and Proposed Rule should be top of mind for product strategy leaders. Read our key takeaways.
It’s Time to Prepare for Medicare Advantage Provider Network Submissions
The countdown for network development, expansion, and Health Service Delivery (HSD) submission for 2020 is upon us. It is imperative that network strategy planning starts now in order to avoid the pitfalls plans have faced in the past.